Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Amy L. Cummings, MD"'
Autor:
Clayton P. Smith, MD, Michael Xiang, MD, PhD, Stephanie M. Yoon, MD, Alan Lee, MD, Dan Ruan, PhD, Jonathan W. Goldman, MD, Amy L. Cummings, MD, Aaron Lisberg, MD, Edward B. Garon, MD, MS, Drew Moghanaki, MD, MPH
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 3, Pp 100468- (2023)
Introduction: Osimertinib is an effective treatment for metastatic NSCLC. Occasionally, thoracic radiation therapy (TRT) is delivered to patients receiving osimertinib to treat residual or progressing pulmonary tumors. Anecdotal reports suggest that
Externí odkaz:
https://doaj.org/article/b2b61572fb9f435fa78b46c90498509e
Autor:
David J. Benjamin, MD, Shuai Chen, PhD, Joanna B. Eldredge, MD, Shiruyeh Schokrpur, MD, Debory Li, Zhikuan Quan, MS, Jason W. Chan, MD, Amy L. Cummings, MD, Megan E. Daly, MD, Jonathan W. Goldman, MD, Matthew A. Gubens, MD, Jeremy P. Harris, MD, Mark W. Onaitis, MD, Viola W. Zhu, MD, PhD, Sandip P. Patel, MD, Karen Kelly, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 12, Pp 100427- (2022)
Introduction: There is a paucity of data on immune checkpoint inhibitors (ICIs) plus doublet chemotherapy (C) in patients with advanced lung cancer whose tumor harbors an actionable mutation. We sought to provide insight into the role of this combina
Externí odkaz:
https://doaj.org/article/3801fd9322224ff8af798db8607d43fe